2-(4-chlorobenzene-6-id-1-yl)-3-methylquinoxaline;2-(4-fluorobenzene-6-id-1-yl)-3-methylquinoxaline;tris(iridium);4-(3-methylquinoxalin-2-yl)benzene-5-ide-1-carbonitrile;2-methyl-3-[4-(trifluoromethyl)benzene-6-id-1-yl]quinoxaline;platinum;tetrakis(pyridine-2-carboxylic acid)
C86H60ClF4Ir3N13O8Pt-4 — CID 158320416
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-chlorobenzene-6-id-1-yl)-3-methylquinoxaline;2-(4-fluorobenzene-6-id-1-yl)-3-methylquinoxaline;tris(iridium);4-(3-methylquinoxalin-2-yl)benzene-5-ide-1-carbonitrile;2-methyl-3-[4-(trifluoromethyl)benzene-6-id-1-yl]quinoxaline;platinum;tetrakis(pyridine-2-carboxylic acid)
2-(4-chlorobenzene-6-id-1-yl)-3-methylquinoxaline;2-(4-fluorobenzene-6-id-1-yl)-3-methylquinoxaline;tris(iridium);4-(3-methylquinoxalin-2-yl)benzene-5-ide-1-carbonitrile;2-methyl-3-[4-(trifluoromethyl)benzene-6-id-1-yl]quinoxaline;platinum;tetrakis(pyridine-2-carboxylic acid) (PubChem CID 158320416) has the molecular formula C86H60ClF4Ir3N13O8Pt-4 and a molecular weight of 2286.68 g/mol. Its IUPAC name is 2-(4-chlorobenzene-6-id-1-yl)-3-methylquinoxaline;2-(4-fluorobenzene-6-id-1-yl)-3-methylquinoxaline;tris(iridium);4-(3-methylquinoxalin-2-yl)benzene-5-ide-1-carbonitrile;2-methyl-3-[4-(trifluoromethyl)benzene-6-id-1-yl]quinoxaline;platinum;tetrakis(pyridine-2-carboxylic acid).
Molecular Properties
| Compound Name | 2-(4-chlorobenzene-6-id-1-yl)-3-methylquinoxaline;2-(4-fluorobenzene-6-id-1-yl)-3-methylquinoxaline;tris(iridium);4-(3-methylquinoxalin-2-yl)benzene-5-ide-1-carbonitrile;2-methyl-3-[4-(trifluoromethyl)benzene-6-id-1-yl]quinoxaline;platinum;tetrakis(pyridine-2-carboxylic acid) |
|---|---|
| PubChem CID | 158320416 |
| Molecular Formula | C86H60ClF4Ir3N13O8Pt-4 |
| Molecular Weight | 2286.68 g/mol |
| Exact Mass | 2287.29 |
| IUPAC Name | 2-(4-chlorobenzene-6-id-1-yl)-3-methylquinoxaline;2-(4-fluorobenzene-6-id-1-yl)-3-methylquinoxaline;tris(iridium);4-(3-methylquinoxalin-2-yl)benzene-5-ide-1-carbonitrile;2-methyl-3-[4-(trifluoromethyl)benzene-6-id-1-yl]quinoxaline;platinum;tetrakis(pyridine-2-carboxylic acid) |
| SMILES | Cc1nc2ccccc2nc1-c1[c-]cc(C#N)cc1.Cc1nc2ccccc2nc1-c1[c-]cc(C(F)(F)F)cc1.Cc1nc2ccccc2nc1-c1[c-]cc(Cl)cc1.Cc1nc2ccccc2nc1-c1[c-]cc(F)cc1.O=C(O)c1ccccn1.O=C(O)c1ccccn1.O=C(O)c1ccccn1.O=C(O)c1ccccn1.[Ir].[Ir].[Ir].[Pt] |
| InChI | InChI=1S/C16H10F3N2.C16H10N3.C15H10ClN2.C15H10FN2.4C6H5NO2.3Ir.Pt/c1-10-15(21-14-5-3-2-4-13(14)20-10)11-6-8-12(9-7-11)16(17,18)19;1-11-16(13-8-6-12(10-17)7-9-13)19-15-5-3-2-4-14(15)18-11;2*1-10-15(11-6-8-12(16)9-7-11)18-14-5-3-2-4-13(14)17-10;4*8-6(9)5-3-1-2-4-7-5;;;;/h2-6,8-9H,1H3;2-8H,1H3;2*2-6,8-9H,1H3;4*1-4H,(H,8,9);;;;/q4*-1;;;;;;;; |
| InChIKey | RXDNMGFIEFIFAG-UHFFFAOYSA-N |
| XLogP | 18.41 |
| TPSA | 327.67 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 116 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2286.68 |
| LogP ≤ 5 | 18.41 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 17 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158320416 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.